- Investing Ideas
- Spanish Pharmaceuticals & Biotech Healthy potentially undervalued
Spanish Pharmaceuticals & Biotech Healthy potentially undervalued
Results
3
Companies which are potentially undervalued and in an acceptable financial position.
3 companies
Laboratorios Farmaceuticos Rovi
Market Cap: €3.1b
Manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally.
ROVI
€60.20
7D
3.4%
1Y
15.0%
Faes Farma
Market Cap: €1.5b
Researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally.
FAE
€4.71
7D
3.9%
1Y
9.9%
Pharma Mar
Market Cap: €1.7b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€100.80
7D
7.2%
1Y
15.9%